Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06150469 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy of Inhaled Aromatherapy on Nausea and Vomiting in Hematological Malignancies

Study acronym: AROM-HEMATO
StatusRecruiting
PhaseNot applicable
Started2024-04-17
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 12, 2024 (before its estimated December 16, 2025 completion). Its status may not reflect the trial's current state.

Amendment history

2024-12-09
Study Identification, Study Status, Oversight, Contacts/Locations v2
Study sites1→4
2024-05-21
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2023-12-16→confirmed 2024-04-17
Study sitesdetails revised at 1 of 1 site
2023-11-20
Original filing
This project will optimise the management of chemotherapy-induced nausea and vomiting, with improvements in nausea and vomiting scores, quality of life and appetite expected in participants benefiting from the intervention. In all cases, the use of complementary methods is recommended and improves the management of people with cancer because they offer a person-centred approach.
Trial Details
NCT Number NCT06150469
Lead Sponsor University Hospital, Limoges
Conditions Hematological Malignancies
Enrollment 286 participants
Start Date 2024-04-17
Primary Completion 2025-12-16 (estimated)
Study Completion 2026-12-16 (estimated)
Updated on ClinicalTrials.gov 2024-12-12